Home › Weill Cornell Medical College And Cellectis Announce Research Alliance Advancing Drug Discovery And The Translation Of Novel Immunotherapies In Leukemia
 

Keywords :   


Weill Cornell Medical College And Cellectis Announce Research Alliance Advancing Drug Discovery And The Translation Of Novel Immunotherapies In Leukemia

2015-06-03 05:49:21| drugdiscoveryonline Home Page

Regulatory News: Weill Cornell Medical College and Cellectis have entered into a strategic translational research alliance to accelerate the development of a targeted immunotherapy for patients with acute myelogenous leukemia (AML), a deadly blood cancer

Tags: in research college medical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11contactglove tundratracker
23.11
23.11RUSSELUNO
23.11C282 800yd IP54
23.11X-FLY4 27.5
23.118
23.11 (1~40)
23.1101DVDBOX
More »